Mohamad W. Alnouri
Bad Nauheim, HE 61231, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
FBiosynthesis and analytics of specialized pro-resolving mediators: facts and faults.
Journal: Journal of lipid research
Published: June 24, 2026
First Structure-Activity-Relationship Study of Potent G2A Antagonists.
Journal: Journal of medicinal chemistry
Published: June 11, 2026
Endothelial insulin resistance induced by adrenomedullin mediates obesity-associated diabetes.
Journal: Science (New York, N.Y.)
Published: February 06, 2025
Identification of a Chemical Probe for BLT2 Activation by Scaffold Hopping.
Journal: Journal of medicinal chemistry
Published: January 13, 2025
SPMs exert anti-inflammatory and pro-resolving effects through positive allosteric modulation of the prostaglandin EP4 receptor.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: October 04, 2024
Subnanomolar MAS-related G protein-coupled receptor-X2/B2 antagonists with efficacy in human mast cells and disease models.
Journal: Signal transduction and targeted therapy
Published: August 14, 2024
Development of a Potent and Selective G2A (GPR132) Agonist.
Journal: Journal of medicinal chemistry
Published: June 25, 2024
Phosphorylation of endothelial histone H3.3 serine 31 by PKN1 links flow-induced signaling to proatherogenic gene expression.
Journal: Nature cardiovascular research
Published: May 14, 2024
A succinate/SUCNR1-brush cell defense program in the tracheal epithelium.
Journal: Science advances
Published: August 02, 2023
The FKBP51 Inhibitor SAFit2 Restores the Pain-Relieving C16 Dihydroceramide after Nerve Injury.
Journal: International journal of molecular sciences
Published: October 26, 2022
Formation, Signaling and Occurrence of Specialized Pro-Resolving Lipid Mediators-What is the Evidence so far?
Journal: Frontiers in pharmacology
Published: December 18, 2021
Last Updated: 09/26/2026